GOLDMAN SACHS GROUP INC - CORMEDIX INC ownership

CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C308. A total of 75 filers reported holding CORMEDIX INC in Q2 2022. The put-call ratio across all filers is 2.15 and the average weighting 1.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORMEDIX INC
ValueSharesWeighting
Q3 2023$158,815
+264.8%
42,923
+290.9%
0.00%
Q2 2023$43,540
-58.5%
10,981
-58.1%
0.00%
Q2 2022$105,000
-58.0%
26,193
-42.6%
0.00%
Q1 2022$250,000
-18.3%
45,642
-32.2%
0.00%
Q4 2021$306,000
+108.2%
67,359
+113.1%
0.00%
Q3 2021$147,000
-19.7%
31,608
+18.8%
0.00%
Q2 2021$183,000
-70.2%
26,609
-56.7%
0.00%
Q1 2021$614,000
+323.4%
61,481
+216.0%
0.00%
Q4 2020$145,000
+133.9%
19,459
+89.6%
0.00%
Q3 2020$62,000
-75.3%
10,263
-63.4%
0.00%
Q2 2019$251,000
-78.5%
28,036
-77.3%
0.00%
Q1 2019$1,169,000123,6950.00%
Other shareholders
CORMEDIX INC shareholders Q2 2022
NameSharesValueWeighting ↓
Spinnaker Capital LLC 175,384$705,000100.00%
Wick Capital Partners, LLC 114,697$461,0000.32%
PLANNING DIRECTIONS INC 50,000$201,0000.15%
Elliott Investment Management L.P. 1,550,523$6,233,0000.07%
NOMURA HOLDINGS INC 5,904,254$22,806,0000.04%
Ergoteles LLC 183,300$737,0000.02%
XTX Topco Ltd 12,100$49,0000.02%
RIVERSEDGE ADVISORS, LLC 11,373$46,0000.02%
Cresset Asset Management, LLC 329,796$1,326,0000.02%
PDT Partners, LLC 41,623$167,0000.02%
View complete list of CORMEDIX INC shareholders